{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:27:58Z","timestamp":1746782878188},"reference-count":18,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T00:00:00Z","timestamp":1121731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective:\u2002<\/jats:bold> Majority of studies on gastroesophageal reflux disease (GERD) that include patients with or without erosive disease have documented the efficacy of proton pump inhibitors (PPIs) as well as their superiority to H<jats:sub>2<\/jats:sub>\u2010receptor antagonist (H<jats:sub>2<\/jats:sub>\u2010RA). The purpose of this study was to clarify the difference in quality of GERD treatment with PPIs and H<jats:sub>2<\/jats:sub>\u2010RA in step\u2010down protocol using lansoprazole.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Forty\u2010three patients with reflux esophagitis were randomly divided into three groups and assessed by severity score; group\u20031 received 30\u2003mg lansoprazole initially and maintenance therapy with a standard dose H<jats:sub>2<\/jats:sub>\u2010RA; group\u20032 received 30\u2003mg of lansoprazole initially and maintenance therapy of 15\u2003mg lansoprazole; and group\u20033 received 15\u2003mg of lansoprazole once daily for 16\u2003weeks. If the patients experienced symptomatic recurrence while on H<jats:sub>2<\/jats:sub>\u2010RA, they were switched to PPI maintenance.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Heartburn, regurgitation and dysphagia were hardly found in any group at 8\u2003weeks after 15\u2003mg or 30\u2003mg lansoprazole treatment. After 8\u2003weeks, however, heartburn and regurgitation recurred at 50% and 78.6%, respectively, in the stepped down to famotidine group, and quality of life (QOL) was significantly impaired. Endoscopic ultrasonography (EUS) analysis showed reduction of the submucosal layer without any change in the mucosal surface in the stepped down to famotidine group.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Step\u2010down lansoprazole therapy is considered very effective in terms of rapid effect, long\u2010term effect and high quality GERD treatment.<\/jats:p><jats:p>\u00a9 2005 Blackwell Publishing Asia Pty Ltd<\/jats:p>","DOI":"10.1111\/j.1440-1746.2005.03980.x","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T13:59:33Z","timestamp":1123682373000},"page":"1365-1370","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management of symptoms in step\u2010down therapy of gastroesophageal reflux disease"],"prefix":"10.1111","volume":"20","author":[{"given":"SHINICHIRO","family":"MINE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKESHI","family":"IIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAHIRO","family":"TABATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROFUMI","family":"KISHIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIYA","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,10]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03933.x"},{"issue":"1","key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000200911","article-title":"Epidemiology and natural history of gastro\u2010oesophageal reflux disease","volume":"51","author":"Spechler SJ","year":"1992","journal-title":"Digestion"},{"issue":"2","key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2036.1997.tb00799.x","article-title":"Management of endoscopy\u2010negative reflux disease: progress with short\u2010term treatment","volume":"11","author":"Lauritsen K","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01757.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529708996533"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8698230"},{"key":"e_1_2_5_8_2","first-page":"170","volume-title":"Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies","author":"Dupuy HJ","year":"1984"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098272"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01206.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199610000-00006"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05517.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220090-00001"},{"key":"e_1_2_5_14_2","first-page":"353","article-title":"Lansoprazole overutilization: methods for step\u2010down therapy","volume":"9","author":"Pohland CJ","year":"2003","journal-title":"Am. J. Manag. Care"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03861.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00558.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00185.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026604203237"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.014s1074.x"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2005.03980.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2005.03980.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:39:41Z","timestamp":1697315981000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2005.03980.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,10]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1440-1746.2005.03980.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2005.03980.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,10]]},"assertion":[{"value":"2005-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}